INSP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	405 642
Average Volume	583 382
Market Cap	4.72B
EPS	$0 ( 2024-05-07 )
Next earnings date	( $0 ) 2024-07-30
Last Dividend	$9.00 ( 2008-01-09 )
Next Dividend	$0 ( N/A )
P/E	-305.37
ATR14	$0.179 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-29	Sparks Charisse Y	Sell	64	Common Stock
2024-05-10	Mccormick Shawn	Buy	2 500	Common Stock
2024-05-10	Mccormick Shawn	Sell	2 500	Stock Option (Right to Buy)
2024-05-02	Burks Cynthia	Buy	716	Common Stock
2024-05-02	Tansey Casey M	Buy	716	Common Stock

INSIDER POWER
5.01
Last 100 transactions
Buy: 146 811 \| Sell: 127 766

Volume Correlation

Long: 0.53 (weak)

Short: 0.98 (very strong)

Signal:(79.762) Expect same movement, but be aware

Inspire Medical Systems Correlation

10 Most Positive Correlations

10 Most Negative Correlations
ZK	-0.885
F-PC	-0.831

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Inspire Medical Systems Correlation - Currency/Commodity

0.79
( moderate )

0.49
( neutral )

0.43
( neutral )

0.56
( weak )

-0.79
( moderate negative )

Inspire Medical Systems Financials

Annual	2023
Revenue:	$624.80M
Gross Profit:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2023
Revenue:	$624.80M
Gross Profit:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2022
Revenue:	$407.86M
Gross Profit:	$341.74M (83.79 %)
EPS:	$-1.600

FY	2021
Revenue:	$233.39M
Gross Profit:	$200.12M (85.74 %)
EPS:	$-1.540

Financial Reports:

No articles found.

Inspire Medical Systems Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Inspire Medical Systems Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.27 - good (72.66%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$9.00	2008-01-09
Last Dividend	$9.00	2008-01-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$9.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	7.27
Div.Growth Potential Score	0
Div. Directional Score	3.46	--

Next Divdend (Est)
(2024-06-03)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.05

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0238	1.500	-0.476	-0.714	[0 - 0.5]
returnOnAssetsTTM	-0.0229	1.200	-0.765	-0.918	[0 - 0.3]
returnOnEquityTTM	-0.0282	1.500	-1.424	-2.14	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.12	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.43	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0357	-1.500	9.40	-10.00	[0 - 0.6]
interestCoverageTTM	-8.39	1.000	-4.22	-4.22	[3 - 30]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.111	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0416	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.847	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0545	1.000	-3.09	-3.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.423	1.000	3.21	3.21	[0.2 - 2]
assetTurnoverTTM	0.964	0.800	6.91	5.53	[0.5 - 2]
Total Score				7.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-298.88	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0282	2.50	-0.915	-2.14	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.111	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-23.44	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0527	1.000	-1.181	0	[0.1 - 0.5]
Total Score				-0.347

Inspire Medical Systems Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.